Host: |
Mouse |
Applications: |
IHC/IF |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Mouse monoclonal antibody anti-Granzyme B (100-200 aa) is suitable for use in Immunohistochemistry and Immunofluorescence research applications. |
Clonality: |
Monoclonal |
Clone ID: |
PT0564 |
Conjugation: |
Unconjugated |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen. |
Dilution Range: |
IF 1:50-200IHC-P 1:50-500 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
GZMB |
Gene ID: |
3002 |
Uniprot ID: |
GRAB_HUMAN |
Immunogen Region: |
100-200 aa |
Specificity: |
This antibody detects endogenous levels of Granzyme B at Human |
Immunogen: |
Synthesized peptide derived from the human 138 at the amino acid range 100-200 |
Protein Name | Granzyme BC11Ctla-1Cathepsin G-Like 1Ctsgl1Cytotoxic T-Lymphocyte Proteinase 2Lymphocyte ProteaseFragmentin-2Granzyme-2Human Lymphocyte ProteinHlpSectT-Cell Serine Protease 1-3e |
Database Links | Reactome: R-HSA-2197563Reactome: R-HSA-5620971Reactome: R-HSA-75108 |
Cellular Localisation | SecretedCytolytic GranuleDelivered Into The Target Cell By Perforin |
Alternative Antibody Names | Anti-Granzyme B antibodyAnti-C11 antibodyAnti-Ctla-1 antibodyAnti-Cathepsin G-Like 1 antibodyAnti-Ctsgl1 antibodyAnti-Cytotoxic T-Lymphocyte Proteinase 2 antibodyAnti-Lymphocyte Protease antibodyAnti-Fragmentin-2 antibodyAnti-Granzyme-2 antibodyAnti-Human Lymphocyte Protein antibodyAnti-Hlp antibodyAnti-Sect antibodyAnti-T-Cell Serine Protease 1-3e antibodyAnti-GZMB antibodyAnti-CGL1 antibodyAnti-CSPB antibodyAnti-CTLA1 antibodyAnti-GRB antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance